CorMedix Inc. (CRMD) earnings
CRMD earnings moved a median of -3.10% by the close. Quarterly and annual CRMD reports and results, each read against the price at its own news timestamp. Back to the CRMD overview →
29 measured CRMD earnings events.
Where these CRMD earnings landedvs 29 measured CRMD earnings reactions
| Middle 50% of CRMD earnings reactions | -7.68% to -0.29% |
|---|---|
| Median reaction (to close) | -3.10% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 CRMD earnings events with a measured close landed between -7.68% and -0.29%; 24% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +0.36% | -3.10% | |
| Form 10-Q CorMedix Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.36% | -3.10% | |
| CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026 | Press release | -0.41% | -2.31% | |
| Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -4.48% | -7.68% | |
| Form 10-Q CorMedix Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.48% | -7.68% | |
| CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026 | Press release | -0.19% | -2.15% | |
| Form 10-K CorMedix Inc. For: Dec 31 | SEC filing · Form 10-K | -1.89% | -0.79% | |
| CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance | Press release | -6.82% | -3.79% | |
| Form 10-Q CorMedix Inc. For: Sep 30 | SEC filing · Form 10-Q | -6.82% | -3.79% | |
| CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025 | Press release | -0.89% | -5.84% | |
| CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance | Press release | -2.63% | +3.23% | |
| Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -14.18% | -10.37% | |
| Form 10-Q CorMedix Inc. For: Jun 30 | SEC filing · Form 10-Q | -14.18% | -10.37% | |
| CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +3.16% | +17.47% | |
| Form 10-Q CorMedix Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.16% | +17.47% | |
| CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 | Press release | -0.77% | +0.66% | |
| Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance | Press release | +2.20% | -9.59% | |
| Form 10-K CorMedix Inc. For: Dec 31 | SEC filing · Form 10-K | -8.23% | -13.65% | |
| CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update | Press release | +6.36% | +2.39% | |
| Form 10-Q CorMedix Inc. For: Sep 30 | SEC filing · Form 10-Q | -11.57% | -11.22% | |
| CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 | Press release | +3.00% | +2.92% | |
| Form 10-Q CorMedix Inc. For: Jun 30 | SEC filing · Form 10-Q | +13.64% | +18.55% | |
| CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024 | Press release | +1.98% | -2.72% | |
| CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -5.64% | -7.52% | |
| Form 10-Q CorMedix Inc. For: Mar 31 | SEC filing · Form 10-Q | -5.64% | -7.52% | |
| CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024 | Press release | +0.00% | -1.01% | |
| Form 10-K CorMedix Inc. For: Dec 31 | SEC filing · Form 10-K | -7.49% | -0.29% | |
| Form 10-Q CorMedix Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.61% | -9.76% | |
| CorMedix Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on November 14, 2023 | Press release | +0.85% | -1.74% |
Keep exploring
More CRMD: analyst actions → · SEC filings → · CRMD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PRESBIA PLC ORDINARY SHARES (LENS) | 270 | 0.00% | 42% |
| Achieve Life Sciences, Inc. - Common Shares (ACHV) | 269 | -0.54% | 42% |
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.